No Data
Hong Kong Stock Movement | Xin Tai Medical (02291) once rose over 28% and closed down more than 14% yesterday after resuming trading. The controlling Shareholder expects uncertainty in sales growth targets.
Xintai Medical (02291) once surged over 28%, and closed down more than 14% upon resuming trading yesterday. Previously, on April 22, the stock had soared more than 100%, then the share price fell back, leading to a trading halt, with an increase of 47.19% at the time of the halt.
LEPU ScienTech Resumes Trading Following Price Share Fluctuations; Shares Fall 14%
Xintai Medical will resume trading starting from the morning of April 23.
Xintai Medical (02291) announced that the company's Listed in Hong Kong shares will resume trading at 9:00 AM on April 23, 2025.
Market Participants Recognise LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.'s (HKG:2291) Earnings Pushing Shares 38% Higher
LEPU ScienTech Medical Technology (Shanghai) And 2 Other Emerging Small Caps With Solid Potential
Xintai Medical (02291.HK): Stock price fluctuation, reason unknown.
On April 22, Gelonghui announced that the Board of Directors noted the recent fluctuations in the price and Volume of the company's shares on the Exchange. It also mentioned that one of the company's controlling shareholders, Lepu (Peking) Medical Instruments Co., Ltd. (whose shares are listed on the GEM at the Shenzhen Stock Exchange, with stock code: 300003), released an investor relations activity record on April 21, 2025. In this record, it mentioned the estimated sales growth target of about 30% for the company's occluder products and an estimated sales target of approximately 0.2 billion yuan for the transcatheter aortic valve replacement products. The realization of these targets carries uncertainty and depends on market conditions.
